Reduction of the Incidence of Amputation in Frostbite Injury With Thrombolytic Therapy

Abstract

Tissue plasminogen activator improved tissue perfusion and reduced amputations when administered within 24 hours of injury. This modality represents the first clinically significant advancement in the treatment of frostbite in more than 25 years.